Actuate Therapeutics Inc
$1.58
+0.35 (+28.46%)
Price as of Aug 25, 2026 market close
Performance
- 1 Month
- +37.4%
- 3 Months
- -28.2%
- YTD
- -74.2%
- 1 Year
- -81.1%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 101.0%
- Largest decline max drawdown, since Aug 2025
- -88.9%
- Risk-adjusted return Sharpe ratio, 1-year
- -1.15
Own ACTU?
See how ACTU contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.